Theranexus and BBDF Obtain Orphan Drug Designation (ODD) and Rare Pediatric Disease Designation (RPDD) from the Food and Drug Administration (FDA) for BBDF-101 for Batten Disease
Orphan Drug Designation (ODD) is a status that provides seven years of additional post-approval protection and exemption from filing fees...